168 HR buprenorphine 0.0075 MG/HR Transdermal System [BuTrans]

RxCUI
1542999
RxNorm name
168 HR buprenorphine 0.0075 MG/HR Transdermal System [BuTrans]
Display name
BUTRANS (Transdermal)
Full name
168 HR buprenorphine 0.0075 MG/HR Transdermal System [BuTrans]
Term type
SBD
Status
Active
Strength
7.5 mcg/hr
Dose form
168 HR Patch
Route
Transdermal
Updated
2026-11-19 15:42:31

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
082014
Active start
082014
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
buprenorphine0.0075 MG / 1 HRbuprenorphinebuprenorphine

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Transdermal System316987

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
buprenorphine1819

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRBuTrans 7.5 MCG/HR 7 Day Transdermal Patch1NAMES
RxNorm Name168 HR buprenorphine 0.0075 MG/HR Transdermal System [BuTrans]1NAMES
RxNorm Synonym
3 linked values
3NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID794aa355-66de-41b8-aedf-f2c40f6bc6641CODES
RxCUI15429991CODES
MMSL_CODEBD297481CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
59011-757-0459011-757Butrans buprenorphineKnoa Pharma LLCNDA021306

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
NDA02130659011-757Butrans buprenorphineNDAKnoa Pharma LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11SourceActive
59011075704rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ButransBUPRENORPHINEKnoa Pharma LLC794aa355-66de-41b8-aedf-f2c40f6bc6642026-05-01Boxed warning, Warnings, Adverse reactionsExact identifier
ndc (package): 59011-757-04
ndc (product): 59011-757
ndc11 (package): 59011075704
rxcui: 1542999

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
794aa355-66de-41b8-aedf-f2c40f6bc664Butrans 7.5 MCG/HR 7 Day Transdermal System [PSN] · 168 HR buprenorphine 0.0075 MG/HR Transdermal System [BuTrans] [SBD] · 168 HR BuTrans 0.0075 MG/HR Transdermal System [SY] · BuTrans 7.5 MCG/HR 7 Day Transdermal Patch [SY] · Butrans 7.5 MCG/HR 7 Day Transdermal System [SY]532These highlights do not include all the information needed to use BUTRANS ® safely and effectively. See full prescribing information for BUTRANS. BUTRANS ® (buprenorphine) transdermal system, CIII Initial U.S. Approval: 198120260501

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
794aa355-66de-41b8-aedf-f2c40f6bc664These highlights do not include all the information needed to use BUTRANS ® safely and effectively. See full prescribing information for BUTRANS. BUTRANS ® (buprenorphine) transdermal system, CIII Initial U.S. Approval: 1981Knoa Pharma LLC | Lohman Therapie System20260501
794aa355-66de-41b8-aedf-f2c40f6bc664These highlights do not include all the information needed to use BUTRANS ® safely and effectively. See full prescribing information for BUTRANS. BUTRANS ® (buprenorphine) transdermal system, CIII Initial U.S. Approval: 1981Knoa Pharma LLC | Lohman Therapie System20260414
794aa355-66de-41b8-aedf-f2c40f6bc664These highlights do not include all the information needed to use BUTRANS ® safely and effectively. See full prescribing information for BUTRANS. BUTRANS ® (buprenorphine) transdermal system, CIII Initial U.S. Approval: 1981Purdue Pharma LP | Lohman Therapie System20251231

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCN07BCDrugs used in opioid dependenceATC1-4buprenorphine
ATCN02AEOripavine derivativesATC1-4buprenorphine
FDASPLN0000175689Partial Opioid AgonistEPChas_epcbuprenorphine
FDASPLN0000175685Partial Opioid AgonistsMOAhas_moabuprenorphine
MEDRTD002047BuprenorphineCHEMhas_ingredientbuprenorphine
MEDRTD004342Drug HypersensitivityDISEASEci_withbuprenorphine
MEDRTD006556Heroin DependenceDISEASEmay_treatbuprenorphine
MEDRTD010146PainDISEASEmay_treatbuprenorphine
MEDRTN0000000154Opioid AntagonistsMOAhas_moabuprenorphine
MEDRTN0000175685Partial Opioid AgonistsMOAhas_moabuprenorphine
MEDRTN0000008768Decreased Organized Electrical ActivityPEhas_pebuprenorphine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.0075 MG/HR
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESQUANTITY168 HR
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE3
CODESNDANDA021306
NAMESPrescribable SynonymButrans 7.5 MCG/HR 7 Day Transdermal System
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon